Filing Details
- Accession Number:
- 0001161697-20-000510
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-02 16:13:51
- Reporting Period:
- 2020-11-30
- Accepted Time:
- 2020-12-02 16:13:51
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
704440 | Repro Med Systems Inc | KRMD | Surgical & Medical Instruments & Apparatus (3841) | 133044880 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1567994 | Horton Capital Partners Fund, L.p. | 1717 Arch Street 39Th Floor Philadelphia PA 19103 | No | No | Yes | No | |
1575443 | Horton Capital Partners, Llc | 1717 Arch Street 39Th Floor Philadelphia PA 19103 | No | No | Yes | No | |
1575444 | Horton Capital Management, Llc | 1717 Arch Street 39Th Floor Philadelphia PA 19103 | No | No | Yes | No | |
1664091 | Jr. M. Joseph Manko | 1717 Arch Street 39Th Floor Philadelphia PA 19103 | Yes | No | Yes | No | |
1767112 | Horton Freedom, L.p. | 1717 Arch Street 39Th Floor Philadelphia PA 19103 | No | No | No | Yes |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-11-30 | 10,000 | $4.56 | 7,436,755 | No | 4 | P | Indirect | By Horton Capital Partners Fund, LP |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By Horton Capital Partners Fund, LP |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 3,283,593 | Indirect | By Horton Freedom, L.P. |
Common Stock | 1,123,110 | Indirect | By Horton Capital Management, LLC |
Footnotes
- See Exhibit 99.1 to this Form 4 for explanation of note (1).
- See Exhibit 99.1 to this Form 4 for explanation of note (2).